Table 5 Characterization of SAHNs by concentration of the stabilizer L-glutamic acid
From: Hyaluronan self-agglomerating nanoparticles for non-small cell lung cancer targeting
Concentration of glutamic acid (M) | Initial | 1 day | 2 days | 4 days | 7 days | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Size* | % SD | Size | % SD | Size | % SD | Size | % SD | Size | % SD | |
0.00 | 108.5 | 3.45 | 219.8 | 1.08 | 232.0 | 3.13 | 243.8 | 5.47 | 262.3 | 6.56 |
0.01 | 126.3 | 2.74 | 146.0 | 0.84 | 153.5 | 1.64 | 160.8 | 3.09 | 166.8 | 4.89 |
0.02 | 147.7 | 3.28 | 154.0 | 1.15 | 160.0 | 2.22 | 161.3 | 2.20 | 163.0 | 2.87 |
0.03 | 139.3 | 1.84 | 179.4 | 0.97 | 190.7 | 0.64 | 198.0 | 1.96 | 228.8 | 1.98 |
0.04 | 141.3 | 2.24 | 183.3 | 0.10 | 194.3 | 1.66 | 207.3 | 2.09 | 211.8 | 4.28 |
0.05 | 180.0 | 2.67 | 185.3 | 1.01 | 197.0 | 1.44 | 238.3 | 2.19 | 219.7 | 4.44 |